Fierce Biotech's Fierce 15, plus a deep dive into drug commercialization strategies
In this episode of "The Top Line," Annalee Armstrong and Gabrielle Masson shine a spotlight on some of the most promising companies in the biotech world. Additionally, you'll have the opportunity to hear from Kevin Dunleavy as he engages in a conversation with Ray Pressburger from Accenture, discussing drug commercialization and the models that are proving to be the most effective.
See omnystudio.com/listener for privacy information.
Create your
podcast in
minutes
It is Free